Recap: Tango Therapeutics Q4 Earnings

Tango Therapeutics TNGX reported its Q4 earnings results on Monday, March 18, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Tango Therapeutics missed estimated earnings by -14.000000000000002%, reporting an EPS of $-0.32 versus an estimate of $-0.28.

Revenue was down $980 thousand from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 6.0% drop in the share price the next day.

Here's a look at Tango Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.34	-0.34	-0.35	-0.35
EPS Actual	-0.23	-0.23	-0.32	-0.33
Revenue Estimate	7.32M	6.95M	6.71M	6.44M
Revenue Actual	10.73M	14.60M	5.77M	6.41M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Tango Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar